Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, et al. Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group. Ophthalmology 2020;127:616–36.
Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106–16.
Pugazhendhi A, Hubbell M, Jairam P, Ambati B. Neovascular macular degeneration: a review of etiology, risk factors, and recent advances in research and therapy. Int J Mol Sci. 2021;22:1170.
Article CAS PubMed PubMed Central Google Scholar
Chen L, Messinger JD, Sloan KR, Swain TA, Sugiura Y, Yannuzzi LA, et al. Nonexudative macular neovascularization supporting outer retina in age-related macular degeneration: a clinicopathologic correlation. Ophthalmology 2020;127:931–47.
Yanagi Y, Mohla A, Lee SY, Mathur R, Chan CM, Yeo I, et al. Incidence of fellow eye involvement in patients with unilateral exudative age-related macular degeneration. JAMA Ophthalmol. 2018;136:905–11.
Article PubMed PubMed Central Google Scholar
de Oliveira DJ, Zhang Q, Garcia J, Zheng F, Motulsky EH, Roisman L, et al. Natural history of subclinical neovascularization in nonexudative age-related macular degeneration using swept-source OCT angiography. Ophthalmology 2018;125:255–66.
von der Emde L, Thiele S, Pfau M, Nadal J, Meyer J, Moller PT, et al. Assessment of exudative activity of choroidal neovascularization in age-related macular degeneration by OCT angiography. Ophthalmologica 2020;243:120–8.
Mettu PS, Allingham MJ, Cousins SW. Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities. Prog Retin Eye Res. 2021;82:100906.
Article CAS PubMed Google Scholar
Carnevali A, Sacconi R, Querques L, Marchese A, Capuano V, Rabiolo A, et al. Natural history of treatment-naive quiescent choroidal neovascularization in age-related macular degeneration using OCT angiography. Ophthalmol Retin. 2018;2:922–30.
Xu D, Davila JP, Rahimi M, Rebhun CB, Alibhai AY, Waheed NK, et al. Long-term progression of type 1 neovascularization in age-related macular degeneration using optical coherence tomography angiography. Am J Ophthalmol. 2018;187:10–20.
Choi M, Kim SW, Yun C, Oh J. OCT angiography features of neovascularization as predictive factors for frequent recurrence in age-related macular degeneration. Am J Ophthalmol. 2020;213:109–19.
Shen M, Zhang Q, Yang J, Zhou H, Chu Z, Zhou X, et al. Swept-source OCT angiographic characteristics of treatment-naive nonexudative macular neovascularization in AMD prior to exudation. Invest Ophthalmol Vis Sci. 2021;62:14.
Article PubMed PubMed Central Google Scholar
Kwon HJ, Lee JJ, Park SW, Byon IS, Lee JE. Enlargement of polypoidal choroidal vasculopathy lesion without exudative findings assessed in en face optical coherence tomography images. Graefes Arch Clin Exp Ophthalmol. 2019;257:1621–9.
Capuano V, Miere A, Querques L, Sacconi R, Carnevali A, Amoroso F, et al. Treatment-naive quiescent choroidal neovascularization in geographic atrophy secondary to nonexudative age-related macular degeneration. Am J Ophthalmol. 2017;182:45–55.
Forte R, Coscas F, Serra R, Cabral D, Colantuono D, Souied EH. Long-term follow-up of quiescent choroidal neovascularisation associated with age-related macular degeneration or pachychoroid disease. Br J Ophthalmol. 2020;104:1057–63.
Cole ED, Ferrara D, Novais EA, Louzada RN, Waheed NK. Clinical trial endpoints for optical coherence tomography angiography in neovascular age-related macular degeneration. Retina. 2016;36:S83–S92.
Ferris FR, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120:844–51.
Wang Y, Bo Q, Jia H, Sun M, Yu Y, Huang P, et al. Small dome-shaped pigment epithelium detachment in polypoidal choroidal vasculopathy: an under-recognized sign of polypoidal lesions on optical coherence tomography? Eye (Lond). 2022;36:733–41.
Article CAS PubMed Google Scholar
Yanagi Y, Mohla A, Lee WK, Lee SY, Mathur R, Chan CM, et al. Prevalence and risk factors for nonexudative neovascularization in fellow eyes of patients with unilateral age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci. 2017;58:3488–95.
Davis MD, Gangnon RE, Lee LY, Hubbard LD, Klein BE, Klein R, et al. The age-related eye disease study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol. 2005;123:1484–98.
Siggel R, Spital C, Lentzsch A, Liakopoulos S. Optical coherence tomography angiography for the detection of macular neovascularization-comparison of en face versus cross-sectional view. Eye (Lond). 2022 Jan 6. Epub ahead of print.
Yang J, Zhang Q, Motulsky EH, Thulliez M, Shi Y, Lyu C, et al. Two-year risk of exudation in eyes with nonexudative age-related macular degeneration and subclinical neovascularization detected with swept source optical coherence tomography angiography. Am J Ophthalmol. 2019;208:1–11.
Article PubMed PubMed Central Google Scholar
Borrelli E, Bandello F, Souied EH, Barresi C, Miere A, Querques L, et al. Neovascular age-related macular degeneration: advancement in retinal imaging builds a bridge between histopathology and clinical findings. Graefes Arch Clin Exp Ophthalmol. 2022;260:2087–93.
Article CAS PubMed Google Scholar
Bo Q, Yan Q, Shen M, Song M, Sun M, Yu Y, et al. Appearance of polypoidal lesions in patients with polypoidal choroidal vasculopathy using swept-source optical coherence tomographic angiography. JAMA Ophthalmol. 2019;137:642–50.
Article PubMed PubMed Central Google Scholar
Solecki L, Loganadane P, Gauthier AS, Simonin M, Puyraveau M, Delbosc B, et al. Predictive factors for exudation of quiescent choroidal neovessels detected by OCT angiography in the fellow eyes of eyes treated for a neovascular age-related macular degeneration. Eye (Lond). 2021;35:644–50.
Lim JH, Wickremasinghe SS, Xie J, Chauhan DS, Baird PN, Robman LD, et al. Delay to treatment and visual outcomes in patients treated with anti-vascular endothelial growth factor for age-related macular degeneration. Am J Ophthalmol. 2012;153:678–86. 686.e1-2
Article CAS PubMed PubMed Central Google Scholar
Liu TY, Shah AR, Del PL. Progression of lesion size in untreated eyes with exudative age-related macular degeneration: a meta-analysis using Lineweaver-Burk plots. JAMA Ophthalmol. 2013;131:335–40.
Article CAS PubMed Google Scholar
Bae K, Kim HJ, Shin YK, Kang SW. Predictors of neovascular activity during neovascular age-related macular degeneration treatment based on optical coherence tomography angiography. Sci Rep. 2019;9:19240.
Article CAS PubMed PubMed Central Google Scholar
Teo K, Yanagi Y, Wong TY, Charkaravarty U, Gemmy CC. Morphologic predictors and temporal characteristics of conversion from nonexudative to exudative age-related macular degeneration in the fellow eye. Ophthalmol Retin. 2021;5:126–40.
Ueta T, Iriyama A, Francis J, Takahashi H, Adachi T, Obata R, et al. Development of typical age-related macular degeneration and polypoidal choroidal vasculopathy in fellow eyes of Japanese patients with exudative age-related macular degeneration. Am J Ophthalmol. 2008;146:96–101.
Sacconi R, Brambati M, Miere A, Costanzo E, Capuano V, Borrelli E, et al. Characterisation of macular neovascularisation in geographic atrophy. Br J Ophthalmol. 2022;106:1282–1287.
Mammadzada P, Corredoira PM, Andre H. The role of hypoxia-inducible factors in neovascular age-related macular degeneration: a gene therapy perspective. Cell Mol Life Sci. 2020;77:819–33.
Article CAS PubMed Google Scholar
Inoue Y, Yanagi Y, Matsuura K, Takahashi H, Tamaki Y, Araie M. Expression of hypoxia-inducible factor 1alpha and 2alpha in choroidal neovascular membranes associated with age-related macular degeneration. Br J Ophthalmol. 2007;91:1720–1.
Article PubMed PubMed Central Google Scholar
Querques G, Souied EH. Vascularized drusen: slowly progressive type 1 neovascularization mimicking drusenoid retinal pigment epithelium elevation. Retina. 2015;35:2433–9.
Rosenfeld PJ, Shapiro H, Tuomi L, Webster M, Elledge J, Blodi B. Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. Ophthalmology. 2011;118:523–30.
Told R, Reiter GS, Mittermuller TJ, Schranz M, Reumueller A, Schlanitz FG, et al. Profiling neovascular age-related macular degeneration choroidal neovascularization lesion response to anti-vascular endothelial growth factor therapy using SSOCTA. Acta Ophthalmol. 2021;99:e240–e246.
Article CAS PubMed Google Scholar
Framme C, Panagakis G, Birngruber R. Effects on choroidal neovascularization after anti-VEGF Upload using intravitreal ranibizumab, as determined by spectral domain-optical coherence tomography. Invest Ophthalmol Vis Sci. 2010;51:1671–6.
Al-Sheikh M, Iafe NA, Phasukkijwatana N, Sadda SR, Sarraf D. Biomarkers of neovascular activity in age-related macular degeneration using optical coherence tomography angiography. Retina. 2018;38:220–30.
留言 (0)